Lund Cardiac MR Group
341 – 350 of 502
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
A fully automatic algorithm for assessing T2* and its certainty value for accurate cardiac and liver iron load determination
2013) 16th Annual SCMR Scientific Sessions In Journal of Cardiovascular Magnetic Resonance 15(Suppl 1).(
- Contribution to journal › Article
-
Mark
Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study
(
- Contribution to journal › Article
-
Mark
Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivo.
(
- Contribution to journal › Article
- 2012
-
Mark
Manual correction of semi-automatic three-dimensional echocardiography is needed for right ventricular assessment in adults; validation with cardiac magnetic resonance
(
- Contribution to journal › Article
-
Mark
Semi-automatic segmentation of myocardium at risk in T2-weighted cardiovascular magnetic resonance
(
- Contribution to journal › Article
-
Mark
Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Quantification of left and right ventricular kinetic energy using four-dimensional intracardiac magnetic resonance imaging flow measurements
(
- Contribution to journal › Article
-
Mark
Cardiac output and cardiac index measured with cardiovascular magnetic resonance in healthy subjects, elite athletes and patients with congestive heart failure
(
- Contribution to journal › Article
-
Mark
Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
(
- Contribution to journal › Article